A Phase 2 Trial of Rituximab and Corticosteroid Therapy for Newly Diagnosed Chronic Graft Versus Host Disease
NCT00350545
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
37
Enrollment
OTHER
Sponsor class
Conditions
Graft vs Host Disease
Interventions
DRUG:
Rituximab
DRUG:
Prednisone
DRUG:
Cyclosporine A
DRUG:
tacrolimus
Sponsor
Stanford University